Hyderabad: AIG Hospitals has introduced PYtest, India’s first clinically validated breath test for detecting Helicobacter pylori infection, developed by Nobel Laureate Barry Marshall.
Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...
A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...
This study evaluated the biological importance of immobilized urease enzyme over the free urease. The support material used for urease immobilization was alginate. Generally, the immobilization of ...
A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. Using a multicancer early detection test, they identified tumor-derived genetic ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. Please bleed more, I thought, looking at ...
The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not. By Pam Belluck A blood test that can help diagnose Alzheimer’s disease has received ...
The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping doctors diagnose Alzheimer's disease in some patients, clearing the ...
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that it can help reduce the need for invasive samples or expensive PET scans.
We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.